Matthew L Morton1, Cheryl L Thompson. 1. Department of Family Medicine and Community Health, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.
Abstract
SCOPE: Increased body mass index (BMI) and decreased serum vitamin D are both known to be associated with increased mortality from breast cancer. However, vitamin D levels are lower in obese individuals in general. Recent studies have sought to determine whether serum vitamin D levels can account for some of the association between higher BMI and increased risk for breast cancer and found that low vitamin D levels in the overweight and obese account for up to 40% of the BMI-attributable risk of developing breast cancer. METHODS AND RESULTS: Here we reviewed the literature to determine if a similar relationship exists between vitamin D, BMI, and breast cancer mortality. Utilizing previously reported independent associations of low vitamin D and high BMI to increases in breast cancer mortality, as well as the known decrement in vitamin D per unit increase in BMI, we estimated that low vitamin D levels may be responsible for roughly 16% of the increased mortality from breast cancer in overweight and obese patients. CONCLUSION: Although this is a relatively small proportion of the effect of obesity, supplements to increase serum vitamin D levels may represent a way to reduce obesity-associated disparities in breast cancer mortality.
SCOPE: Increased body mass index (BMI) and decreased serum vitamin D are both known to be associated with increased mortality from breast cancer. However, vitamin D levels are lower in obese individuals in general. Recent studies have sought to determine whether serum vitamin D levels can account for some of the association between higher BMI and increased risk for breast cancer and found that low vitamin D levels in the overweight and obese account for up to 40% of the BMI-attributable risk of developing breast cancer. METHODS AND RESULTS: Here we reviewed the literature to determine if a similar relationship exists between vitamin D, BMI, and breast cancer mortality. Utilizing previously reported independent associations of low vitamin D and high BMI to increases in breast cancer mortality, as well as the known decrement in vitamin D per unit increase in BMI, we estimated that low vitamin D levels may be responsible for roughly 16% of the increased mortality from breast cancer in overweight and obesepatients. CONCLUSION: Although this is a relatively small proportion of the effect of obesity, supplements to increase serum vitamin D levels may represent a way to reduce obesity-associated disparities in breast cancer mortality.
Authors: Sharif B Mohr; Edward D Gorham; John E Alcaraz; Christopher J Kane; Caroline A Macera; J Kellogg Parsons; Deborah L Wingard; Cedric F Garland Journal: Anticancer Res Date: 2011-09 Impact factor: 2.480
Authors: Bette J Caan; Marilyn L Kwan; Georgina Hartzell; Adrienne Castillo; Martha L Slattery; Barbara Sternfeld; Erin Weltzien Journal: Cancer Causes Control Date: 2008-08-28 Impact factor: 2.506
Authors: Irene Orlow; Anne S Reiner; Nancy E Thomas; Pampa Roy; Peter A Kanetsky; Li Luo; Susan Paine; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Stefano Rosso; Roberto Zanetti; Stephen B Gruber; Hoda Anton-Culver; Richard P Gallagher; Terence Dwyer; Klaus Busam; Colin B Begg; Marianne Berwick Journal: Carcinogenesis Date: 2015-10-31 Impact factor: 4.944